BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8733244)

  • 1. [Plasma kallikrein clearance by the liver in experimental cirrhosis].
    de Toledo CF; Loureiro-Silva MR; Molina HM; Lanzoni VP; Kouyoumdjian M; Borges DR
    Rev Assoc Med Bras (1992); 1995; 41(6):367-72. PubMed ID: 8733244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma kallikrein clearance by the liver of chronic carbon tetrachloride-treated rats.
    Toledo CF; Kouyoumdjian M; Lanzoni VP; Borges DR
    J Gastroenterol Hepatol; 1995; 10(2):165-8. PubMed ID: 7787162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma-kallikrein clearance by the liver of acetaminophen-intoxicated rats.
    de Toledo CF; Borges DR
    Life Sci; 1993; 52(17):1451-9. PubMed ID: 8464345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native plasma kallikrein is cleared at similar rates by mammalian and avian livers.
    Borges DR; Kouyoumdjian M; Limãos EA
    Braz J Med Biol Res; 1991; 24(1):63-5. PubMed ID: 1823219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat plasma kallikrein clearance by perfused rat liver.
    Borges DR; Gordon AH; Guimarães JA; Prado JL
    Braz J Med Biol Res; 1985; 18(2):187-94. PubMed ID: 3006849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma kallikrein clearance by the liver: a review.
    Borges DR; Kouyoumdjian M
    Braz J Med Biol Res; 1994 Aug; 27(8):2033-41. PubMed ID: 7538375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic clearance of tissue-type plasminogen activator and plasma kallikrein in experimental liver fibrosis.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Liver Int; 2003 Dec; 23(6):476-83. PubMed ID: 14986822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma-kallikrein clearance during liver regeneration after partial hepatectomy in the rat.
    Braulio VB; Kouyoumdjian M; Zucoloto S; Figueiredo F; Borges DR
    Liver; 1998 Dec; 18(6):371-7. PubMed ID: 9869390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between clearance rates of plasma kallikrein and of plasma kallikrein-alpha-macroglobulin complexes by the liver.
    Ogata H; Kouyoumdjian M; Borges DR
    Int J Biochem; 1993 Jul; 25(7):1047-51. PubMed ID: 7689988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
    Callaghan R; Desmond PV; Paull P; Mashford ML
    Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenobarbitone-induced enlargement of the liver in the rat: its relationship to carbon tetrachloride-induced cirrhosis.
    Chatamra K; Proctor E
    Br J Exp Pathol; 1981 Jun; 62(3):283-8. PubMed ID: 7248170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental cirrhosis of the liver obtained with simultaneous carbon tetrachloride and phenobarbital sodium].
    Colombo P; Savio S; Cavallero M; Fiaccadori C
    Arch Sci Med (Torino); 1973; 130(3):188-97. PubMed ID: 17342914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.
    Matsuda Y; Matsumoto K; Yamada A; Ichida T; Asakura H; Komoriya Y; Nishiyama E; Nakamura T
    Hepatology; 1997 Jul; 26(1):81-9. PubMed ID: 9214455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malotilate completely inhibits CCl4-induced liver cirrhosis in rats: biochemical and morphological analysis.
    Suzuki T
    Fukushima J Med Sci; 1992 Jun; 38(1):19-33. PubMed ID: 1292970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue kallikrein clearance by the liver--effect of plasma components on kallikrein uptake by cultured rat hepatocytes.
    Aoki K; Kamada M; Ikekita M; Kizuki K; Moriya H
    Agents Actions Suppl; 1992; 38 ( Pt 2)():157-64. PubMed ID: 1462824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
    Fenyves D; Gariépy L; Villeneuve JP
    Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effects of a fermented substance from Saccharomyces cerevisiae on carbon tetrachloride-induced liver damage in rats.
    Lai JT; Hsieh WT; Fang HL; Lin WC
    Clin Nutr; 2009 Jun; 28(3):338-45. PubMed ID: 19233522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma kallikrein and thrombin are cleared through unrelated hepatic pathways.
    Loureiro-Silva MR; Kouyoumdjian M; Borges DR
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):551-4. PubMed ID: 8218851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.